Neuronetics (NASDAQ: STIM) 10% holder buys 1,057,400 shares

Rhea-AI Filing Summary

Neuronetics, Inc. 10% owner Jorey Chernett reported significant open-market buying of the company’s common stock. On March 18, 2026, he purchased 607,400 shares at a weighted average price of $1.35 per share in multiple trades. On March 19, 2026, he bought an additional 450,000 shares at a weighted average price of $1.33 per share, also across multiple transactions. Following these purchases, Chernett directly owns 8,573,804 shares of Neuronetics common stock.

Insider Trade Summary

Net Buyer: 1,057,400 shares ($1,418,490)

Net Buy 2 txns

Insider Chernett Jorey

Role 10% Owner

Bought 1,057,400 shs ($1.42M)

Type	Security	Shares	Price	Value
Purchase	Common Stock	450,000	$1.33	$599K
Purchase	Common Stock	607,400	$1.35	$820K

Holdings After Transaction: Common Stock — 8,573,804 shares (Direct)

Footnotes (1)

1. The price reported in Column 4 is a weighted average price, rounded to the nearest cent. These shares were purchased in multiple transactions at prices ranging from $1.33 to $1.37, rounded to the nearest cent, inclusive. Mr. Chernett undertakes to provide the Issuer and any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price such shares were purchased. The price reported in Column 4 is a weighted average price, rounded to the nearest cent. These shares were purchased in multiple transactions at prices ranging from $1.29 to $1.48, rounded to the nearest cent, inclusive. Mr. Chernett undertakes to provide the Issuer and any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price such shares were purchased.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Chernett Jorey

(Last) (First) (Middle)

6222 INDIANWOOD TR.

(Street)

BLOOMFIELD HILLS MICHIGAN 48301

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Neuronetics, Inc. [ STIM ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/18/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/18/2026		P		607,400	A	$1.35(1)	8,123,804	D
Common Stock	03/19/2026		P		450,000	A	$1.33(2)	8,573,804	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The price reported in Column 4 is a weighted average price, rounded to the nearest cent. These shares were purchased in multiple transactions at prices ranging from $1.33 to $1.37, rounded to the nearest cent, inclusive. Mr. Chernett undertakes to provide the Issuer and any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price such shares were purchased.

2. The price reported in Column 4 is a weighted average price, rounded to the nearest cent. These shares were purchased in multiple transactions at prices ranging from $1.29 to $1.48, rounded to the nearest cent, inclusive. Mr. Chernett undertakes to provide the Issuer and any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price such shares were purchased.

	/s/ Jorey Chernett	03/20/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider activity did Neuronetics (STIM) report in this Form 4?

Neuronetics reported that 10% owner Jorey Chernett made open-market purchases of its common stock. He bought a total of 1,057,400 shares over two days, increasing his direct ownership stake in the company.

How many Neuronetics (STIM) shares did Jorey Chernett buy and at what prices?

Jorey Chernett purchased 607,400 shares at a weighted average of $1.35 on March 18, 2026, and 450,000 shares at a weighted average of $1.33 on March 19, 2026, through multiple open-market transactions.

What is Jorey Chernett’s total Neuronetics (STIM) ownership after these transactions?

After the reported purchases, Jorey Chernett directly owns 8,573,804 shares of Neuronetics common stock. This reflects his status as a 10% owner and shows the updated position following the March 2026 open-market buys.

Were the Neuronetics (STIM) insider purchases single trades or multiple transactions?

Each day’s reported price is a weighted average from multiple trades. Footnotes state the March 19 trades ranged from $1.33 to $1.37, and the March 18 trades ranged from $1.29 to $1.48, all rounded to the nearest cent.

What type of transaction code is shown in the Neuronetics (STIM) Form 4?

The Form 4 uses transaction code P, described as an open-market or private purchase. Both reported transactions are classified as non-derivative common stock buys, indicating direct share purchases rather than option exercises or derivative conversions.